Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Growth Shares
How you could have turned $10,000 into $440,000 in 10 years
⏸️ ASX Shares
Are these healthcare shares in the buy zone?
52-Week Highs
These 3 ASX shares just raced to 52-week highs: Is it too late to invest?
Speculative
3 small cap tech shares to watch this month
Growth Shares
3 small cap healthcare shares that could be destined for big things
52-Week Highs
These 3 ASX shares just hit 52-week highs: Is it too late to invest?
⏸️ ASX Shares
5 exciting small cap shares to watch in FY 2019
Share Gainers
Is this the best small cap healthcare share on the ASX?
Share Gainers
These 3 small cap ASX shares are on the rise on Monday
Growth Shares
These healthcare shares could be great long term investments
Speculative
3 exciting small cap healthcare shares on my watchlist
Speculative
5 explosive small cap tech shares to watch
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.
